Skip to main content
Caplight Logo









GeneQuantum Healthcare

GeneQuantum Healthcare

Private
SuzhouHealthcare & Life Scienceshttps://www.genequantum.com/

Last Round

Series C

May 18, 2021

Total Funding Raised

$5.8M

Company Overview

GeneQuantum Healthcare is a biotechnology company that develops a new generation of bioconjugate therapeutics, such as antibody-drug conjugates (ADCs), to address unmet medical needs for cancer patients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

antibody-drug conjugatesADCssite-specific conjugationbioconjugation technologyenzymatic conjugationADC platformoncologynext-generation ADCscancer therapytechnology licensingclinical-stage biotechdrug discoverysolid tumorsantibody immune agonist conjugateAIAC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GeneQuantum Healthcare Comparables

Compare GeneQuantum Healthcare with similar companies based on industry and business-model similarity.

GeneQuantum Healthcare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Duality Biotherapeutics Inc
85%
Multitude Therapeutics
84%
Aimed Bio Inc.
82%

GeneQuantum Healthcare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMay 18, 2021
Series BNov 19, 2020
Series BOct 1, 2020
VC RoundMay 7, 2019
Series AMar 27, 2017

GeneQuantum Healthcare Investors

Notable investors and investment history

GeneQuantum Healthcare investors
InvestorRounds
TF CapitalSeries A, VC Round
PICC Capital Equity Investment Co., Ltd.Series C
Huagai CapitalVC Round
China Life Private Equity InvestmentSeries C
Oriza Seed Venture CapitalVC Round, Series A
Fontus CapitalVC Round, Series A
China Life Private Equity Investment Co., Ltd.Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2025

    Launched iDiscovery and iConjugation systems for XDC discovery and manufacturing.

  • Jul 1, 2025

    Partnerships established with Henlius, Biohaven, and BrightGene.

GeneQuantum Healthcare Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GeneQuantum Healthcare Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GeneQuantum Healthcare's valuation, stock price, and market status.

Firmographic Details

HeadquartersSuzhou
Employee Range15
Year Founded2013
Last FundingMay 18, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?